Seeking Alpha

  Stemline Therapeutics - NASDAQ

11/24/2014, 9:29 AM ET
  • Holdem-Hero | Send Message 6 Jun

    Aegis Capital Lifts PT on $STML to $75 !!! SL-401 Progressing Nicely
      STML vs. ETF Alternatives
      Company Description
      Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.